PharmaCyte Biotech, Inc. Financial Ratios — PMCB Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025	04/30/2026

Return on Common Equity (%)	- -	- -	- -	-118.76	-84.81	-60.83	-98.57	-75.26	-75.57	-60.35	-8.78	-5.31	-4.35	74.24	-46.03
Return on Assets (%)	-114.15	-64.38	-447.04	-106.67	-73.69	-56.15	-90.57	-66.7	-64.05	-52.34	-8.65	-5.27	0.5	53.28	-38.12
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.59	67.08	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-11.58	-9.54	- -
Gross Margin (%)	70.88	20.89	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	-2,891.5	-13,851.65	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	-2,928.55	-13,851.65	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	142,226.82	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-2,853.62	-13,142.29	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	-2,853.62	-13,142.29	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	-2,853.62	-13,142.29	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	115.28	-3.83	0.16
Sustainable Growth Rate (%)	- -	- -	- -	-118.76	-84.81	-60.83	-98.57	-75.26	-75.57	-60.35	-8.78	-5.31	0.67	77.08	-45.96

Credit (USD)

Credit Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025	04/30/2026

Total Debt	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
ST Debt	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	-1.09	-0.25	- -	- -	- -	- -	- -	- -	-0.02	- -	- -	- -	- -	- -	- -
Net Debt/EBITDA	-1.08	-0.13	0.19	0.2	0.32	0.78	0.15	0.13	0.21	0.61	19.44	10.54	7.7	3.47	3.51
Total Debt/EBIT	-1.07	-0.25	- -	- -	- -	- -	- -	- -	-0.02	- -	- -	- -	- -	- -	- -
Net Debt/EBIT	-1.07	-0.13	0.19	0.2	0.32	0.78	0.15	0.13	0.21	0.61	19.44	10.54	7.7	3.47	3.51
EBITDA to Interest Expense	-7.98	-10.91	-901.49	- -	- -	- -	- -	- -	-8,446.79	-1,189.42	-8,628.71	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-7.98	-15.1	-1,067.74	- -	- -	- -	- -	- -	-8,446.79	-1,189.42	-8,628.71	- -	- -	- -	- -
EBIT to Interest Expense	-8.08	-10.91	-901.49	- -	- -	- -	- -	- -	-8,446.79	-1,189.42	-8,628.71	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-109.21	-52.19	95.99	83.65	91.09	93.31	89.96	87.15	82.52	90.21	99.22	99.2	46.15	94.06	72.11
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.91	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.9	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.75	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	-123.09	-45.58	- -	- -	- -	- -	- -	- -	1.48	- -	- -	- -	- -	- -	- -
Total Debt/Capital (%)	533.03	-83.76	- -	- -	- -	- -	- -	- -	1.46	- -	- -	- -	- -	- -	- -
Total Debt/Total Assets (%)	100.23	14.6	- -	- -	- -	- -	- -	- -	1.22	- -	- -	- -	- -	- -	- -
Net Debt to Equity	-122.17	-23.95	-40.44	-34.71	-29.45	-42.84	-18.37	-10.22	-16.11	-32.97	-94.97	-93.6	-126.99	-29.24	-53.18
Net Debt/Capital (%)	551.1	-31.49	-67.9	-53.17	-41.74	-74.93	-22.51	-11.39	-19.2	-49.18	-1,889.77	-1,463.1	470.5	-41.32	-113.6
EBITDA	-2	-2	-19	-13	-6	-4	-7	-4	-4	-4	-4	-6	-7	-4	-5
EBITDA-CapEx	-2	-2	-22	-13	-6	-4	-7	-4	-4	-4	-4	-6	-7	-4	-5
Operating Income (Loss)	-2	-2	-19	-13	-6	-4	-7	-4	-4	-4	-4	-6	-7	-4	-5

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025	04/30/2026

Cash Ratio	- -	0.05	9.68	1.78	3.01	5.97	1.65	0.69	0.87	3.04	121.24	115.99	6.76	5.33	44.87
Current Ratio	0.28	0.49	11.2	2.74	3.18	6.1	1.99	0.88	1.01	3.14	121.38	116.18	6.8	7.68	45.28
Quick Ratio	- -	0.05	9.68	1.78	3.01	5.97	1.65	0.69	0.87	3.04	121.24	115.99	6.76	6.6	45.16
CFO/Avg Current Liab	-0.07	-0.1	-0.75	-4.82	-4.03	-5.48	-8.3	-4.15	-2.64	-3.79	-5.76	-5.88	-0.54	-0.58	-2.76
Common Equity/Total Assets	-109.21	-52.19	95.99	83.65	91.09	93.31	89.96	87.15	82.52	90.21	99.22	99.2	46.15	94.06	72.11
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.91	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.9	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.75	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	-123.09	-45.58	- -	- -	- -	- -	- -	- -	1.48	- -	- -	- -	- -	- -	- -
Total Debt/Capital (%)	533.03	-83.76	- -	- -	- -	- -	- -	- -	1.46	- -	- -	- -	- -	- -	- -
Total Debt/Total Assets (%)	100.23	14.6	- -	- -	- -	- -	- -	- -	1.22	- -	- -	- -	- -	- -	- -
CFO/Total Liabilities	-6.85	-10.28	-416.07	-299.94	-681.64	-575.52	-788.52	-387.41	-216.98	-459.57	-584.54	-646.75	-10.55	-90.88	-43.77
CFO/CapEx	- -	-0.6	-0.44	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	-31.34	-15.47	311.35	20.16	14.14	48.85	-2.01	-28.22	-37.27	-5.52	40.33	48.69	-1.76	-0.51	-2.17

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025	04/30/2026

Accounts Receivable Turnover	27.18	9.42	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	13.43	38.74	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	1.52	2.81	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	240.58	129.87	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	0.01	0.01	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	34,831.74	71,188.42	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	-34,577.73	-71,019.81	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	-227.16	-91.14	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025	04/30/2026

Market Capitalization	- -	47	211	117	55	73	57	50	42	44	48	49	17	8	8
- Cash & Cash Equivalents	- -	- -	4	3	2	3	1	1	1	2	85	68	50	15	19
+ Preferred Equity and Hybrid Capital	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	12	- -	1
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	3	48	207	115	53	69	56	50	41	41	-37	-19	-21	-7	-28
Total Capital	- -	-1	9	8	7	8	6	5	5	7	90	73	40	52	35
Total Debt/Capital (%)	533.03	-83.76	- -	- -	- -	- -	- -	- -	1.46	- -	- -	- -	- -	- -	- -
Total Debt / EV	0.79	0.01	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales	39.92	3,939.42	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	116.63	105.24	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	43	178	113	53	68	54	47	34	40	36	57	20	9	6
Diluted Enterprise Value	3	44	174	110	51	65	53	46	33	38	-49	-11	-18	-6	-11
EV per Share	9.57	148.97	449.25	234.88	102.49	115.01	82.13	62.9	37.22	26.05	- -	- -	- -	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-2	-2	-19	-13	-6	-4	-7	-4	-4	-4	-4	-6	-7	-4	-5
TTM Operating Income	-2	-2	-19	-13	-6	-4	-7	-4	-4	-4	-4	-6	-7	-4	-5
TTM Cash Flow to Firm	- -	- -	-2	-5	-4	-3	-5	-3	-2	-3	-4	-4	-2	-3	-5
TTM Free Cash Flow to Firm	- -	- -	2	-5	-4	-3	-5	-3	-2	-3	-4	-4	-2	-3	-5

Multiples (USD)

Valuation Multiples API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025	04/30/2026

Price/Free Cash Flow	- -	168.08	91.41	-24.77	-12.26	-20.39	-10.65	-16.2	-14.68	-11.93	-8.78	-15	-9.44	-3.05	-1.17
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	3	48	207	115	53	69	56	50	41	41	-37	-19	-21	-7	-28
Low Price	- -	38.75	143.38	147.25	59.67	35.65	46.81	55.8	36.42	6.2	1.79	1.95	1.92	1.03	0.63
EV/Sales	39.92	3,939.42	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.31	- -
Price/Earnings Average	- -	-14.76	-3.96	-15.29	-12.06	-14.44	-8.88	-14.97	-14.15	-9.94	-23.71	-12.15	-10.6	0.44	-0.38
Price/Earnings High	- -	-28.24	-13.72	-24.93	-21.49	-33.22	-13.93	-29.36	-25.26	-23.39	-103.29	-14	-14.17	0.6	-0.64
Price/Earnings Low	- -	-7.13	-2.05	-6.97	-4.94	-4.52	-4.43	-10.07	-8.6	-2.53	-6.55	-8.81	-8.42	0.26	-0.27
Price/Book Value	- -	-31.37	23.55	15.11	8.48	9.02	9.81	9.98	8.15	6.53	0.54	0.67	0.62	0.16	0.23
Price/Book Value Average	- -	-17.18	14.3	20.3	11.64	8.5	11	13.02	12.87	5.8	1.49	0.62	0.7	0.23	0.29
Price/Book Value High	- -	-32.86	49.5	33.11	20.74	19.55	17.25	25.55	22.97	13.65	6.5	0.72	0.94	0.32	0.48
Price/Book Value Low	- -	-8.3	7.39	9.25	4.77	2.66	5.48	8.76	7.82	1.48	0.41	0.45	0.56	0.13	0.2
Price/Tangible Book Value	- -	-31.37	39.04	27.79	18.61	16.07	25.49	33.74	26.96	13.93	0.56	0.71	0.65	0.17	0.23
Price/Tangible Book Value Average	- -	-17.18	23.7	37.35	25.53	15.14	28.6	44.04	42.53	12.39	1.55	0.65	0.74	0.24	0.29
Price/Tangible Book Value High	- -	-32.86	82.08	60.91	45.5	34.84	44.84	86.4	75.93	29.13	6.77	0.75	0.99	0.33	0.48
Price/Tangible Book Value Low	- -	-8.3	12.25	17.02	10.46	4.74	14.26	29.62	25.86	3.15	0.43	0.47	0.59	0.14	0.2
Price/Sales	- -	3,542.94	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	1,940.34	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	3,711.52	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	937.25	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	-110.35	-114.37	-24.77	-12.26	-20.39	-10.65	-16.2	-14.68	-11.93	-8.78	-15	-9.44	-3.05	-1.17
Price/Cash Flow Average	- -	-60.43	-69.44	-33.28	-16.82	-19.21	-11.94	-21.15	-23.16	-10.6	-24.41	-13.82	-10.75	-4.32	-1.47
Price/Cash Flow High	- -	-115.6	-240.45	-54.27	-29.98	-44.2	-18.73	-41.5	-41.34	-24.94	-106.35	-15.93	-14.38	-5.96	-2.46
Price/Cash Flow Low	- -	-29.19	-35.88	-15.17	-6.89	-6.02	-5.95	-14.23	-14.08	-2.7	-6.75	-10.02	-8.55	-2.53	-1.02
Price/Free Cash Flow Average	- -	92.05	55.49	-33.28	-16.82	-19.21	-11.94	-21.15	-23.16	-10.6	-24.41	-13.82	-10.75	-4.32	-1.47
Price/Free Cash Flow High	- -	176.07	192.17	-54.27	-29.98	-44.2	-18.73	-41.5	-41.34	-24.94	-106.35	-15.93	-14.38	-5.96	-2.46
Price/Free Cash Flow Low	- -	44.46	28.67	-15.17	-6.89	-6.02	-5.95	-14.23	-14.08	-2.7	-6.75	-10.02	-8.55	-2.53	-1.02
EV/Sales Average	39.92	2,187.27	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	39.92	4,123.74	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	39.92	1,090.57	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-1.38	-15.79	-6.54	-11.7	-12.18	-14.69	-8.94	-15.88	-16.9	-10.09	-11.11	3.54	2.9	0.74	1.44
EV/EBITDA High	-1.38	-29.77	-23.13	-19.21	-21.96	-34.81	-14.1	-31.27	-30.33	-24.56	-113.65	2.48	1.89	-0.29	0.21
EV/EBITDA Low	-1.38	-7.87	-3.29	-5.22	-4.8	-4.07	-4.38	-10.64	-10.19	-2.11	11	5.47	3.51	1.87	1.99
EV/EBIT Average	-1.36	-15.79	-6.54	-11.7	-12.18	-14.69	-8.94	-15.88	-16.9	-10.09	-11.11	3.54	2.9	0.74	1.44
EV/EBIT High	-1.36	-29.77	-23.13	-19.21	-21.96	-34.81	-14.1	-31.27	-30.33	-24.56	-113.65	2.48	1.89	-0.29	0.21
EV/EBIT Low	-1.36	-7.87	-3.29	-5.22	-4.8	-4.07	-4.38	-10.64	-10.19	-2.11	11	5.47	3.51	1.87	1.99
Last Price	- -	146.48	457.1	240.4	106.18	120.75	83.7	63.55	37.97	27.43	2.33	2.92	2.12	1.24	0.72
High Price	- -	153.45	961	526.84	259.63	261.8	147.25	162.75	106.95	57.35	28.21	3.1	3.23	2.42	1.51
Enterprise Value Average	3	27	124	155	74	65	62	65	65	37	49	-23	-19	-3	-8
Enterprise Value High	3	50	439	255	133	155	98	128	116	89	499	-16	-12	1	-1
Enterprise Value Low	3	13	62	69	29	18	31	44	39	8	-48	-35	-23	-8	-11

Shares Outstanding	- -	- -	- -	- -	1	1	1	1	1	2	21	17	8	7	11
Diluted Weighted Avg Shares	- -	- -	- -	- -	1	1	1	1	1	1	16	19	10	7	8
Basic Weighted Avg Shares	- -	- -	- -	- -	1	1	1	1	1	1	16	19	10	7	8
Revenue per Share	0.27	0.04	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-7.7	-5.73	-48.79	-28.23	-12.1	-7.88	-10.81	-5.59	-4.23	-2.5	-0.28	-0.33	-0.68	-0.6	-0.63
Operating Income per Share	-7.8	-5.73	-48.79	-28.23	-12.1	-7.88	-10.81	-5.59	-4.23	-2.5	-0.28	-0.33	-0.68	-0.6	-0.63
Basic EPS, GAAP	-7.6	-5.43	-70.06	-21.13	-12.08	-7.88	-10.57	-5.54	-4.23	-2.45	-0.27	-0.22	-0.23	4.03	-2.35
Basic EPS from Cont Ops	-7.6	-5.43	-70.06	-21.13	-12.08	-7.88	-10.57	-5.54	-4.23	-2.45	-0.27	-0.22	0.03	4.18	-2.32
Diluted EPS, GAAP	-7.6	-5.43	-70.06	-21.13	-12.08	-7.88	-10.57	-5.54	-4.23	-2.45	-0.27	-0.22	-0.23	4.03	-2.35
Diluted EPS from Cont Ops	-7.6	-5.43	-70.06	-21.13	-12.08	-7.88	-10.57	-5.54	-4.23	-2.45	-0.27	-0.22	0.03	4.18	-2.32
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.03
Cash Flow per Share	-1.04	-1.33	-4	-9.71	-8.66	-5.92	-7.86	-3.92	-2.59	-2.3	-0.27	-0.19	-0.22	-0.41	-0.62
Free Cash Flow per Basic Share	-1.04	-3.53	-12.99	-9.71	-8.66	-5.92	-7.86	-3.92	-2.59	-2.3	-0.27	-0.19	-0.22	-0.41	-0.62
Cash & Equivalents per Share	0.06	0.62	7.85	5.52	3.69	5.74	1.57	0.65	0.82	1.38	4.12	4.05	6.24	2.29	3.45
Book Value per Share	-8.21	-4.67	19.41	15.91	12.52	13.39	8.54	6.37	4.66	4.2	4.34	4.33	3.44	7.64	3.14
Tangible Book Value per Share	-8.21	-4.67	11.71	8.65	5.71	7.51	3.28	1.88	1.41	1.97	4.17	4.12	3.25	7.41	3.14

PharmaCyte Biotech, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)